» Articles » PMID: 32947488

Proteomics of Non-human Primate Plasma After Partial-body Radiation with Minimal Bone Marrow Sparing

Overview
Journal Health Phys
Date 2020 Sep 18
PMID 32947488
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

High-dose radiation exposure results in organ-specific sequelae that occurs in a time- and dose-dependent manner. The partial body irradiation with minimal bone marrow sparing model was developed to mimic intentional or accidental radiation exposures in humans where bone marrow sparing is likely and permits the concurrent analysis of coincident short- and long-term damage to organ systems. To help inform on the natural history of the radiation-induced injury of the partial body irradiation model, we quantitatively profiled the plasma proteome of non-human primates following 12 Gy partial body irradiation with 2.5% bone marrow sparing with 6 MV LINAC-derived photons at 0.80 Gy min over a time period of 3 wk. The plasma proteome was analyzed by liquid chromatography-tandem mass spectrometry. A number of trends were identified in the proteomic data including pronounced protein changes as well as protein changes that were consistently upregulated or downregulated at all time points and dose levels interrogated. Pathway and gene ontology analysis were performed; bioinformatic analysis revealed significant pathway and biological process perturbations post high-dose irradiation and shed light on underlying mechanisms of radiation damage. Additionally, proteins were identified that had the greatest potential to serve as biomarkers for radiation exposure.

Citing Articles

Sex differences in radiation research.

Taliaferro L, Agarwal R, Coleman C, DiCarlo A, Hofmeyer K, Loelius S Int J Radiat Biol. 2023; 100(3):466-485.

PMID: 37991728 PMC: 10922591. DOI: 10.1080/09553002.2023.2283089.


Proteomic Analysis to Identify Prospective Biomarkers of Treatment Outcome After Microvascular Decompression for Trigeminal Neuralgia: A Preliminary Study.

Doshi T, Dorsey S, Huang W, Kane M, Lim M J Pain. 2023; 25(3):781-790.

PMID: 37838347 PMC: 10922145. DOI: 10.1016/j.jpain.2023.10.006.


The NIAID/RNCP Biodosimetry Program: An Overview.

Satyamitra M, Cassatt D, Molinar-Inglis O, Rios C, Taliaferro L, Winters T Cytogenet Genome Res. 2023; 163(3-4):89-102.

PMID: 37742625 PMC: 10946631. DOI: 10.1159/000534213.


Introducing BDNF and SNAI1 as the Crucial Targeted Genes by UV Radiation.

Mansouri V, Arjmand B, Hamzeloo-Moghadam M, Razzaghi Z, Khodadoost M, Rezaei Tavirani M J Lasers Med Sci. 2023; 13:e76.

PMID: 37041787 PMC: 10082910. DOI: 10.34172/jlms.2022.76.


Radiation-Induced Intestinal Normal Tissue Toxicity: Implications for Altered Proteome Profile.

Larrey E, Pathak R Genes (Basel). 2022; 13(11).

PMID: 36360243 PMC: 9689954. DOI: 10.3390/genes13112006.


References
1.
Chen C, Perry T, Chitko-McKown C, Smith A, Cheung L, Beshah E . The regulatory actions of retinoic acid on M2 polarization of porcine macrophages. Dev Comp Immunol. 2019; 98:20-33. DOI: 10.1016/j.dci.2019.03.020. View

2.
Kane M, Folias A, Wang C, Napoli J . Quantitative profiling of endogenous retinoic acid in vivo and in vitro by tandem mass spectrometry. Anal Chem. 2008; 80(5):1702-8. PMC: 4086453. DOI: 10.1021/ac702030f. View

3.
Martinez-Ceballos E, Chambon P, Gudas L . Differences in gene expression between wild type and Hoxa1 knockout embryonic stem cells after retinoic acid treatment or leukemia inhibitory factor (LIF) removal. J Biol Chem. 2005; 280(16):16484-98. DOI: 10.1074/jbc.M414397200. View

4.
Blakely W, Ossetrova N, Whitnall M, Sandgren D, Krivokrysenko V, Shakhov A . Multiple parameter radiation injury assessment using a nonhuman primate radiation model-biodosimetry applications. Health Phys. 2010; 98(2):153-9. DOI: 10.1097/HP.0b013e3181b0306d. View

5.
Prado C, MacVittie T, Bennett A, Kazi A, Farese A, Prado K . Organ Doses Associated with Partial-Body Irradiation with 2.5% Bone Marrow Sparing of the Non-Human Primate: A Retrospective Study. Radiat Res. 2017; 188(6):615-625. DOI: 10.1667/RR14804.1. View